Browse the complete list of publications for PLCO.
Filter results of publications table below
| Title | PubMed | Authors | Journal | Year | Studies |
|---|---|---|---|---|---|
| Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry. | 36703164 | Mueller SH, Lai AG, Valkovskaya M, Michailidou K, Bolla MK, Wang Q, Dennis J, Lush M, Abu-Ful Z, Ahearn TU, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Aronson KJ, Augustinsson A, Baert T, Freeman LEB, Beckmann MW, Behrens S, Benitez J, Be… | Genome Med | 2023 | PLCO |
| Integrated spatial transcriptomics and lipidomics of precursor lesions of pancreatic cancer identifies enrichment of long chain sulfatide biosynthesis as an early metabolic alteration. | 37645752 | Sans M, Chen Y, Thege FI, Dou R, Min J, Yip-Schneider M, Zhang J, Wu R, Irajizad E, Makino Y, Rajapakshe KI, Hurd MW, León-Letelier RA, Vykoukal J, Dennison JB, Do KA, Wolff RA, Guerrero PA, Kim MP, Schmidt CM, Maitra A, Hanash S, Fahrmann JF | bioRxiv | 2023 | PLCO |
| Deep learning to estimate lung disease mortality from chest radiographs. | 37193717 | Weiss J, Raghu VK, Bontempi D, Christiani DC, Mak RH, Lu MT, Aerts HJWL | Nat Commun | 2023 | NLST, PLCO |
| Advancing prostate cancer detection: a comparative analysis of PCLDA-SVM and PCLDA-KNN classifiers for enhanced diagnostic accuracy. | 37612436 | Dubey P, Kumar S | Sci Rep | 2023 | PLCO |
| PCA-KNN Classifier for Improved Diagnostic Accuracy: A Study on Prostate Cancer | P. Dubey and S. Kumar | ICCCNT | 2023 | PLCO | |
| The association between genetically elevated polyunsaturated fatty acids and risk of cancer. | 37086649 | Haycock PC, Borges MC, Burrows K, Lemaitre RN, Burgess S, Khankari NK, Tsilidis KK, Gaunt TR, Hemani G, Zheng J, Truong T, Birmann BM, OMara T, Spurdle AB, Iles MM, Law MH, Slager SL, Saberi Hosnijeh F, Mariosa D, Cotterchio M, Cerhan JR, Peters U, … | EBioMedicine | 2023 | PLCO |
| Estimation and inference of predictive discrimination for survival outcome risk prediction models. | 35061146 | Li R, Ning J, Feng Z | Lifetime Data Anal | 2022 | PLCO |
| Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment. | 34995129 | Fahrmann JF, Marsh T, Irajizad E, Patel N, Murage E, Vykoukal J, Dennison JB, Do KA, Ostrin E, Spitz MR, Lam S, Shete S, Meza R, Tammemägi MC, Feng Z, Hanash SM | J Clin Oncol | 2022 | PLCO |
| Inflammatory potential of diet and colorectal carcinogenesis: a prospective longitudinal cohort. | 35136208 | Li Z, Wang K, Shivappa N, Hébert JR, Chen H, Liu H, Jiang X | Br J Cancer | 2022 | PLCO |
| Weight Change and Incident Distal Colorectal Adenoma Risk in the PLCO Cancer Screening Trial. | 35112050 | He S, Berndt SI, Kunzmann AT, Kitahara CM, Huang WY, Barry KH | JNCI Cancer Spectr | 2022 | PLCO |
| Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis. | 35113855 | Yarmolinsky J, Díez-Obrero V, Richardson TG, Pigeyre M, Sjaarda J, Paré G, Walker VM, Vincent EE, Tan VY, Obón-Santacana M, Albanes D, Hampe J, Gsur A, Hampel H, Pai RK, Jenkins M, Gallinger S, Casey G, Zheng W, Amos CI, International Lung Cancer Co… | PLoS Med | 2022 | PLCO |
| Associations Between Glycemic Traits and Colorectal Cancer: A Mendelian Randomization Analysis. | 35048991 | Murphy N, Song M, Papadimitriou N, Carreras-Torres R, Langenberg C, Martin RM, Tsilidis KK, Barroso I, Chen J, Frayling TM, Bull CJ, Vincent EE, Cotterchio M, Gruber SB, Pai RK, Newcomb PA, Perez-Cornago A, van Duijnhoven FJB, Van Guelpen B, Vodicka… | J Natl Cancer Inst | 2022 | PLCO |
| Prediction of future risk of any and higher-grade prostate cancer based on the PLCO and SELECT trials. | 35351104 | Gelfond JA, Hernandez B, Goros M, Ibrahim JG, Chen MH, Sun W, Leach RJ, Kattan MW, Thompson IM, Ankerst DP, Liss M | BMC Urol | 2022 | PLCO |
| IPRS: Leveraging Gene-Environment Interaction to Reconstruct Polygenic Risk Score. | 35401709 | Tang Y, You D, Yi H, Yang S, Zhao Y | Front Genet | 2022 | PLCO |
| Body mass index and risk of progression from monoclonal gammopathy of undetermined significance to multiple myeloma: Results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. | 35365600 | Chang VC, Khan AA, Huang WY, Katki HA, Purdue MP, Landgren O, Hofmann JN | Blood Cancer J | 2022 | PLCO |
| Alu Retroelement Copy Number and Lung Cancer Risk in the Prospective Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. | 35609672 | Wong JYY , Cawthon R , Hu W , Ezennia S , Gadalla SM , Breeze C , Blechter B , Freedman ND , Huang WY , Hosgood HD , Seow WJ , Bassig BA , Rahman ML , Hayes RB , Rothman N , Lan Q | Chest | 2022 | PLCO |
| Prospective Associations of Circulating Bile Acids and Short-Chain Fatty Acids With Incident Colorectal Cancer. | 35583137 | Loftfield E, Falk RT, Sampson JN, Huang WY, Hullings A, Murphy G, Weinstein SJ, Albanes D, Freedman ND, Sinha R | JNCI Cancer Spectr | 2022 | PLCO |
| Association Between Diabetes Risk Reduction Diet and Lung Cancer Risk in 98,159 Participants: Results From a Prospective Study. | 35574372 | Zhang Y, Zhong G, Zhu M, Chen L, Wan H, Luo F | Front Oncol | 2022 | PLCO |
| Serum Pepsinogen as a Biomarker for Gastric Cancer in the United States: A Nested Case-Control Study Using the PLCO Cancer Screening Trial Data. | 35534235 | In H, Sarkar S, Ward J, Friedmann P, Parides M, Yang J, Epplein M | Cancer Epidemiol Biomarkers Prev | 2022 | PLCO |
| Genetic variants in DDO and PEX5L in peroxisome-related pathways predict non-small cell lung cancer survival. | 35502931 | Chen AS, Liu H, Wu Y, Luo S, Patz EF, Glass C, Su L, Du M, Christiani DC, Wei Q | Mol Carcinog | 2022 | PLCO |